A recent study in COVID-19 host genetics found that BATF2 controls the production of cytokines from CD4+ T-cells and macrophages in mice [69] and participates in interferon signaling [70], highlighting a potential immunotherapeutic target to mitigate COVID-19. This evidence concerns the gene CD4 and COVID-19.